Disorders of Sleep and Breathing
- In OSA, 3 to 4 Hours of Nightly PAP Use Significantly Lowers Hospitalizations
- Risk for COVID-19 and Related Complications Greater in Those With Recent OSA
- Positive Airway Pressure Adherence in OSA Reduces Long-Term Cost of Care
- Intranasal Saline Reduces Sleep-Disordered Breathing Symptoms in Children
- Modification of Adipocytokine Levels May Improve Obstructive Sleep Apnea
- Severe Obstructive Sleep Apnea May Lead to Worse Post-Stroke Prognosis
- A Month of Nightly Atomoxetine-Oxybutynin Treatment for OSA Is Safe, Effective
- Glaucoma More Likely in Individuals at Risk For Sleep Apnea
- Sex and Multiple Factors Influencing Respiratory Event Duration in Sleep Apnea
- Concomitant OSA Leads to Greater Functional Performance Decline in COPD
- Sleep Apnea Common in Men With Idiopathic Intracranial Hypertension
- Is CPAP Use Beneficial in Patients with OSA and Diabetic Kidney Disease?
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
